Michelle F. Magee, MD, is an endocrinologist at MedStar Washington Hospital Center (MWHC), a principal investigator at MedStar Health Research Institute (MHRI), and an associate professor of Medicine at Georgetown University School of Medicine, Washington, DC.
At MedStar, Dr. Magee serves as director of the MedStar Diabetes Institute (MDI). In this capacity she leads and supports diabetes clinical, educational and research programs. These programs include diabetes ambulatory care, hospital glycemic management services and research across MedStar Health, and diabetes education in the community. Dr. Magee's work focuses on high risk, minority and underserved populations with or at risk for diabetes.
Dr. Magee is currently leading a MedStar Health initiative to provide survival skills self-care education and intensive medication management to adults with uncontrolled type 2 diabetes through an evidence-based 12-week boot-camp program. She also is leading the NIH-funded Diabetes to Go study, an innovative technology-assisted program created to provide inpatient diabetes self-care education and care transition planning at hospital discharge for patients with diabetes.
In addition, Dr. Magee has participated as an investigator on more than 50 clinical studies, including the landmark NIH Diabetes Prevention Program (DPP) and Women's Health Initiative studies. She has served as a co-principal investigator for the NIH “Bypass Angioplasty Revascularization Investigation Type 2 Diabetes Study” at MWHC and for “Changing the Healthcare Delivery Model: A Community Health Worker/Mobile Chronic Care Team Strategy,” funded by the Patient-Centered Outcomes Research Institute and conducted in collaboration with George Washington and Howard Universities.
Under Dr. Magee's leadership, MDI delivers blood pressure screenings in DC community barber shops and Lifestyle Balance diabetes prevention programs, which have collectively provided free health education services to almost 4,000 DC residents at risk for cardiovascular disease (CVD) and/or diabetes.
At the national level, Dr. Magee has served or serves the American Diabetes Association (ADA), the American Heart Association (The Guideline Advantage), the Society of Hospital Medicine, the Endocrine Society, and the American Association of Diabetes Educators. Dr. Magee has received an ADA Promising Practice Award of Excellence and a Microsoft Health Users Award for her innovative work on web-based personal health records. She has been listed as a “Super Doctor” in the DC-Baltimore-Northern Virginia area for 3 years in a row.
Her medical degree is from the Royal College of Surgeons in Ireland. She completed a residency in internal medicine and a fellowship in endocrinology and metabolism at George Washington University.
Dr. Magee's research interests include the following:
- Type 2 diabetes
- Diabetes therapeutics and complications
- Disparities in diabetes care
- Hospital management of diabetes
- Readmissions rate reduction
- Health technology
- Hypertension and related co-morbidities
- Cardiovascular disease
- Diabetes self-care management education
MedStar Diabetes Pathway Boot Camp
This 12-week diabetes boot-camp style program, led by Dr. Magee, is funded by MedStar Health. The program combines technology-enabled diabetes survival skills education with intensive medication management to improve outcomes among adults living with uncontrolled type 2 diabetes. Virtual visits and algorithm-driven diabetes medication titration are conducted by endocrinologist-supervised Certified Diabetes Educators who are registered nurses, registered dieticians, nurse practitioners, or professional pharmacists. This program has demonstrated evidence of dramatically improved hemoglobin A1C and reduced risk for readmissions to the emergency department or hospital.
View the MedStar Pathway to Diabetes Control Demonstration protocol here.
Diabetes to Go
With funding from a National Institutes of Health (NIH) R34 award, Dr. Magee is collaborating on this study of how to best enable nurses to provide diabetes-survival skills information to patients in the hospital. This work will provide focused diabetes education, improve medication-taking behaviors after hospital discharge, and prevent rehospitalization for diabetes. Combining MedStar’s transdisciplinary expertise in implementation science, human factors, innovation, nursing research and specialized diabetes education, this program will determine how unit nurses can optimally deliver key information to diabetes patients that will help them to live safely and well with their diabetes following discharge from the hospital.
This program, developed in collaboration with the District of Columbia Department of Health and Department of Parks and Recreation, focuses on combating obesity and diabetes and has been made available at area recreation centers, churches and worksites. The programming is based on the NIH's Diabetes Prevention Program curriculum. Participants in this MDI community program have had outcomes similar to those generated by the DPP.
Hair, Heart, and Health
This MHRI and MDI health screening program is provided in barbershops in DC. The program has screened more than 800 high-risk DC residents for hypertension, a risk factor for CVD. This program empowers shop owners to advocate for and provide blood pressure screening for their patrons. Shop owners have been trained to measure blood pressure and navigate clients to appropriate follow-up services. Of the mostly African-American participants, 93% are overweight or obese and almost 25% had undiagnosed hypertension.
Stop Emergency Room Visits for Hyperglycemia Project -- District of Columbia (STEP-DC)
The STEP-DC study was funded initially by the District of Columbia Department of Health. In this study, the impact of medication management, health system navigation, and survival skills education on emergency department patients with uncontrolled type 2 diabetes was evaluated. Participants in the pilot program had improved blood glucose measures after a 4-week intervention. Dr. Magee received further funding from the ADA to conduct a prospective, randomized, controlled trial, which further tested the impact of this intervention.
- Research Areas
- Health Services/Quality/Outcomes